access to relevant anonymised patient level data (Eli Lilly)
90
Structured Review
Eli Lilly
access to relevant anonymised patient level data
Access To Relevant Anonymised Patient Level Data, supplied by Eli Lilly, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/access+to+relevant+anonymised+patient+level+data/anonymized+patient+data/pmc06135452-142-11-3
Average 90 stars, based on 1 article reviews
Access To Relevant Anonymised Patient Level Data, supplied by Eli Lilly, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/access+to+relevant+anonymised+patient+level+data/anonymized+patient+data/pmc06135452-142-11-3
Average 90 stars, based on 1 article reviews
access to relevant anonymised patient level data - by Bioz Stars,
2026-11
90/100 stars
Images
Related Articles
other:Article Title: Ixekizumab is efficacious when used alone or when added to conventional synthetic disease-modifying antirheumatic drugs (cDMARDs) in patients with active psoriatic arthritis and previous inadequate response or intolerance to tumour necrosis factor inhibitors Article Snippet: Data sharing statement: |